KRISTEN VEILLON: Open Payments
NPI 1043755911 · BUNKIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 9 payments from 4 companies in 2025. Trend: 2023 $144 · 2024 $309 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, ABILIFY MAINTENA, XIFAXAN, REXULTI, UBRELVY.
Industry payments across LA — which companies pay providers there.
